259 related articles for article (PubMed ID: 12171583)
1. Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development.
Schmidt A; Krauth-Siegel RL
Curr Top Med Chem; 2002 Nov; 2(11):1239-59. PubMed ID: 12171583
[TBL] [Abstract][Full Text] [Related]
2. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
Krauth-Siegel RL; Meiering SK; Schmidt H
Biol Chem; 2003 Apr; 384(4):539-49. PubMed ID: 12751784
[TBL] [Abstract][Full Text] [Related]
3. Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents.
Augustyns K; Amssoms K; Yamani A; Rajan PK; Haemers A
Curr Pharm Des; 2001 Aug; 7(12):1117-41. PubMed ID: 11472257
[TBL] [Abstract][Full Text] [Related]
4. A tryparedoxin-coupled biosensor reveals a mitochondrial trypanothione metabolism in trypanosomes.
Ebersoll S; Bogacz M; Günter LM; Dick TP; Krauth-Siegel RL
Elife; 2020 Jan; 9():. PubMed ID: 32003744
[TBL] [Abstract][Full Text] [Related]
5. Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism.
Krauth-Siegel RL; Comini MA
Biochim Biophys Acta; 2008 Nov; 1780(11):1236-48. PubMed ID: 18395526
[TBL] [Abstract][Full Text] [Related]
6. Parasite-specific trypanothione reductase as a drug target molecule.
Krauth-Siegel RL; Inhoff O
Parasitol Res; 2003 Jun; 90 Suppl 2():S77-85. PubMed ID: 12709793
[TBL] [Abstract][Full Text] [Related]
7. Targeting Trypanothione Metabolism in Trypanosomatids.
González-Montero MC; Andrés-Rodríguez J; García-Fernández N; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; García-Estrada C
Molecules; 2024 May; 29(10):. PubMed ID: 38792079
[TBL] [Abstract][Full Text] [Related]
8. The trypanothione system and its implications in the therapy of trypanosomatid diseases.
Flohé L
Int J Med Microbiol; 2012 Oct; 302(4-5):216-20. PubMed ID: 22889611
[TBL] [Abstract][Full Text] [Related]
9. Thiol-based redox metabolism of protozoan parasites.
Müller S; Liebau E; Walter RD; Krauth-Siegel RL
Trends Parasitol; 2003 Jul; 19(7):320-8. PubMed ID: 12855383
[TBL] [Abstract][Full Text] [Related]
10. Preparative enzymatic synthesis of trypanothione and trypanothione analogues.
Comini MA; Dirdjaja N; Kaschel M; Krauth-Siegel RL
Int J Parasitol; 2009 Aug; 39(10):1059-62. PubMed ID: 19477177
[TBL] [Abstract][Full Text] [Related]
11. Recent Advancement in the Search of Innovative Antiprotozoal Agents Targeting Trypanothione Metabolism.
Saccoliti F; Di Santo R; Costi R
ChemMedChem; 2020 Dec; 15(24):2420-2435. PubMed ID: 32805075
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of inhibitors of the trypanothione cycle.
D'Silva C; Daunes S
Expert Opin Investig Drugs; 2002 Feb; 11(2):217-31. PubMed ID: 11829713
[TBL] [Abstract][Full Text] [Related]
13. Molecular studies on trypanothione reductase, a target for antiparasitic drugs.
Walsh C; Bradley M; Nadeau K
Trends Biochem Sci; 1991 Aug; 16(8):305-9. PubMed ID: 1957352
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamylcysteine synthetase and tryparedoxin 1 exert high control on the antioxidant system in Trypanosoma cruzi contributing to drug resistance and infectivity.
González-Chávez Z; Vázquez C; Mejia-Tlachi M; Márquez-Dueñas C; Manning-Cela R; Encalada R; Rodríguez-Enríquez S; Michels PAM; Moreno-Sánchez R; Saavedra E
Redox Biol; 2019 Sep; 26():101231. PubMed ID: 31203195
[TBL] [Abstract][Full Text] [Related]
15. Targeting trypanothione metabolism in trypanosomatid human parasites.
Olin-Sandoval V; Moreno-Sánchez R; Saavedra E
Curr Drug Targets; 2010 Dec; 11(12):1614-30. PubMed ID: 20735352
[TBL] [Abstract][Full Text] [Related]
16. Flavoprotein structure and mechanism. 5. Trypanothione reductase and lipoamide dehydrogenase as targets for a structure-based drug design.
Krauth-Siegel RL; Schöneck R
FASEB J; 1995 Sep; 9(12):1138-46. PubMed ID: 7672506
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of trypanothione reductase as potential antitrypanosomal drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari RA; Douglas KT; Fairlamb AH; Croft SL
Biochem Soc Trans; 1995 Nov; 23(4):511S. PubMed ID: 8654696
[No Abstract] [Full Text] [Related]
18. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
19. Trypanothione metabolism and rational approaches to drug design.
Fairlamb AH
Biochem Soc Trans; 1990 Oct; 18(5):717-20. PubMed ID: 2083656
[No Abstract] [Full Text] [Related]
20. Key proteins in the polyamine-trypanothione pathway as drug targets against Trypanosoma cruzi.
Maya JD; Salas CO; Aguilera-Venegas B; Diaz MV; López-Muñoz R
Curr Med Chem; 2014; 21(15):1757-71. PubMed ID: 24251576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
